Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepagina
  2. Aandelen
  3. Zwitserland
  4. Swiss Exchange
  5. Roche Holding AG
  6. Nieuws
  7. Persberichten
    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Rapport
Vertraagde tijd Swiss Exchange  -  17:31 30-09-2022
323.45 CHF   +1.00%
29/09ROCHE HOLDINGS AG : UBS vindt het aandeel niet inspirerend
MD
29/09ROCHE HOLDINGS AG : Deutsche Bank handhaaft het Neutraal advies
MD
29/09ROCHE HOLDINGS AG : Een koopadvies van Barclays
MD
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuwsAnalyse MarketScreener
Communiquťs de presse de la sociťtť ROCHE HOLDING AG
30/09Xoma - EC Approved, VABYSMO for the Treatment of nAMD and DME
AQ
26/09GSK plc - Iain Mackay, Chief Financial Officer, to retire from GSK, Julie Brown appoint..
AQ
26/09Change in the Roche Board of Directors
AQ
20/09Invitation to Roche's 3rd Quarter Sales 2022 Webinar
AQ
19/09Genentech And Samsung Bioepis Settle Bevacizumab Biosimilar Patent Dispute
AQ
08/09Tanvex Answers Genentech's Trastuzumab Complaint
AQ
07/09Good Therapeutics Announces Acquisition of Conditionally Active PD-1-regulated IL-2 Pro..
BU
07/09PTAB Institutes IPRs Of Tocilzumab Patents Challenged By Celltrion
AQ
31/08Curis, Inc. - FDA Allows Patient Enrollment to Resume in Monotherapy Dose Escalation of..
AQ
23/08Roche launches a digital PCR system, a powerful new diagnostics platform in the fight a..
AQ
17/08FDA accepts supplemental Biologics License Application for Roche's Polivy combination f..
AQ
16/08Genentech - FDA Accepts Supplemental Biologics License Application for Genentech's Poli..
AQ
16/08FDA Accepts Supplemental Biologics License Application for Genentech's Polivy Combinati..
BU
16/08FDA accepts supplemental Biologics License Application for Roche's Polivy combination f..
GL
15/08Roche launches new diagnostic test for the better understanding of immune response to S..
GL
12/08Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five y..
AQ
11/08Genentech Announces FDA Approval of Xofluza to Treat Influenza in Children Aged Five an..
BU
11/08Chugai Pharmaceutical Co., Ltd. - Anti-C5 Recycling Antibody Crovalimab Obtains Priorit..
AQ
09/08Chugai Pharmaceutical Co., Ltd. - Notice of the Settlement of Patent Infringement Litig..
AQ
08/08Chugai Pharmaceutical Co., Ltd. - Maruho Launched in Japan the Anti-IL-31 Receptor a Hu..
AQ
02/08Genentech's Subcutaneous Formulation of Tecentriq Demonstrates Positive Phase III Resul..
BU
02/08Roche's subcutaneous formulation of Tecentriq demonstrates positive Phase III results
AQ
29/07Lending & Secured Finance 2022
AQ
28/07Genentech to Present Scientific Progress Across Alzheimer's Disease Pharmaceutical and ..
BU
22/07CHMP recommends EU approval of Roche's Vabysmo, the first bispecific antibody for the e..
AQ
21/07Roche : Semi-Annal Report
PU
21/07Chugai Pharmaceutical Co., Ltd. - F. Hoffmann-La Roche Announces Half Year Results 2022
AQ
21/07Roche : Half-Year 2022 Presentation
PU
21/07[ad Hoc Announcement Pursuant To Art : Change in the Board of Directors and Corporate Exec..
GL
21/07[Ad hoc announcement pursuant to Art. 53 LR] Roche achieves good results in the first s..
GL
19/07Roche's Elecsys Amyloid Plasma Panel granted FDA Breakthrough Device Designation to ena..
AQ
18/07Roche launches innovative dual antigen and antibody diagnostic test supporting the figh..
GL
15/07Chugai's Osteoporosis Agent Edirol Launched in China
AQ
15/07New Two-Year Data Confirm Genentech's Vabysmo Improves Vision with Fewer Treatments for..
AQ
14/07Eight-year data from APHINITY study show Roche's Perjeta-based regimen continues to red..
AQ
14/07New Two-Year Data Confirm Genentech's Vabysmo Improves Vision With Fewer Treatments for..
BU
14/07New two-year data confirm Roche's Vabysmo improves vision with fewer treatments for peo..
AQ
13/07Chugai Pharmaceutical Continues to be Listed for All ESG Indices Selected by GPIF
AQ
12/07New Data From Phase III Haven 6 Study Reinforce Favorable Safety and Efficacy Profile o..
AQ
12/07Chugai Pharmaceutical Co., Ltd. - Primary Analysis of Japanese Phase III Clinical Trial..
AQ
12/07Chugai Pharmaceutical Co., Ltd. - New Data from Phase III HAVEN 6 Study Reinforce Favor..
AQ
12/07ViiV, Roche and Pfizer top in ESG, according to patients
AQ
12/07New data from phase III HAVEN 6 study reinforce favourable safety and efficacy profile ..
AQ
11/07New Data From Phase III HAVEN 6 Study Reinforce Favorable Safety and Efficacy Profile o..
BU
11/07New data from phase III HAVEN 6 study reinforce favourable safety and efficacy profile ..
AQ
06/07FDA Grants Priority Review to Genentech's Mosunetuzumab for People with Relapsed or Ref..
AQ
06/07FDA Grants Priority Review to Genentech's Mosunetuzumab for People With Relapsed or Ref..
BU
23/06Galderma Announces Topline Results of OLYMPIA 2 Study Evaluating Nemolizumab in Prurigo..
AQ
21/06Kenya : Ministry signs agreement to enhance access to breast cancer treatment
AQ
21/06Kenya : Ministry signs agreement to enhance access to breast cancer treatment Breast cance..
AQ
17/06Nordic Bioscience and Roche Diagnostics Strengthen Collaboration for Development of Bio..
AQ
16/06Roche provides update on Alzheimer's Prevention Initiative study evaluating crenezumab ..
AQ
16/06Roche launches human papillomavirus (HPV) self-sampling solution, expanding cervical ca..
AQ
16/06Genentech Provides Update on Alzheimer's Prevention Initiative Study Evaluating Crenezu..
BU
16/06Roche provides update on Alzheimer's Prevention Initiative study evaluating crenezumab ..
GL
15/06Roche receives FDA EUA for cobas SARS-CoV-2 Duo, the first PCR test to simultaneously d..
AQ
13/06Roche announces positive data from broad blood cancer portfolio at European Hematology ..
AQ
10/06Genentech Announces Positive Data from Broad Blood Cancer Portfolio at European Hematol..
BU
09/06U.S. FDA approves Foundation Medicine's FoundationOneģCDx as a companion diagnostic for..
AQ
09/06European Commission approves Roche's Tecentriq as adjuvant treatment for a subset of pe..
GL
08/06Kazia Therapeutics Limited - PHASE II STUDY OF PAXALISIB IN BRAIN METASTASES ADVANCES T..
AQ
08/06Chugai Receives DX Grand Prix 2022 Awards in Digital Transformation Stocks (DX Stocks) ..
AQ
08/06European Commission approves Roche's first-in-class bispecific antibody Lunsumio for pe..
GL
07/06GBT's Inclacumab and GBT601 Receive U.S. FDA Orphan Drug and Rare Pediatric Disease Des..
AQ
07/06Chugai Supports the Japan Climate Initiative's Calling to Raise Renewable Energy Target
AQ
06/06New Bpcia Complaint : Genentech Files Suit Against Tanvex Regarding Its Proposed Herceptin..
AQ
06/06Chugai Obtains Regulatory Approval for FoundationOne CDx Cancer Genomic Profile to be U..
AQ
01/06Beijing IP Court Hears China's First Patent Linkage Case
AQ
31/05PTC Therapeutics, Inc. - FDA Approves Label Extension for Evrysdi for Infants with Spin..
AQ
31/05FDA Approves Genentech's Evrysdi (risdiplam) for Use in Babies Under Two Months With Sp..
BU
31/05FDA approves Roche's Evrysdi for use in babies under two months with spinal muscular at..
AQ
27/05New pivotal data demonstrate clinical benefit of Roche's glofitamab, a potential first-..
GL
26/05New Pivotal Data Demonstrate Clinical Benefit of Genentech's Glofitamab, a Potential Fi..
BU
26/05Chugai Launches Vabysmo Intravitreal Injection 120 mg/mL for the Treatment of Age-relat..
AQ
26/05Roche's Polivy combination approved by European Commission for people with previously u..
AQ
1  2  3  4  5  6  7  8  9  10Volgende